tiprankstipranks
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
Want to see ELTP full AI Analyst Report?

Elite Pharmaceuticals (ELTP) Financial Statements

376 Followers

Elite Pharmaceuticals Financial Overview

Elite Pharmaceuticals's market cap is currently $331.76M. The company's EPS TTM is $0.05; its P/E ratio is 5.65; Elite Pharmaceuticals is scheduled to report earnings on August 13, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Jun 25Jun 24Mar 23Mar 22
Income Statement
Total Revenue$ 148.87M$ 84.04M$ 56.63M$ 34.16M$ 32.26M
Gross Profit$ 73.48M$ 40.09M$ 26.36M$ 16.59M$ 14.80M
Operating Income$ 49.96M$ 19.60M$ 10.79M$ 2.03B$ 5.07M
EBITDA$ 51.98M$ 2.84M$ 2.52M$ 6.43M$ 6.49M
Net Income$ 44.87M$ -4.31M$ 20.11M$ 4.41M$ 8.90M
Balance Sheet
Cash & Short-Term Investments$ 29.80B$ 11.32M$ 7.11M$ 7.83M$ 8.54M
Total Assets$ 138.29M$ 96.39M$ 83.65M$ 40.90M$ 35.15M
Total Debt$ 5.82M$ 10.91M$ 11.74M$ 3.89M$ 2.78M
Net Debt$ -29.79B$ -400.50K$ 4.63M$ -3.94M$ -5.75M
Total Liabilities$ 39.41M$ 42.87M$ 26.07M$ 11.94M$ 9.93M
Stockholders' Equity$ 98.88M$ 53.52M$ 57.58M$ 28.96M$ 25.22M
Cash Flow
Free Cash Flow$ 22.82B$ 4.93M$ -4.09M$ -2.40M$ 6.01M
Operating Cash Flow$ 23.75B$ 7.46M$ -3.28M$ 3.34M$ 6.51M
Investing Cash Flow$ -925.63M$ -2.40M$ -809.65K$ -5.74M$ -498.57K
Financing Cash Flow$ -4.32B$ -825.74K$ 3.39M$ 1.70M$ -667.13K
Currency in USD

Elite Pharmaceuticals Earnings and Revenue History

Elite Pharmaceuticals Debt to Assets

Elite Pharmaceuticals Cash Flow

Elite Pharmaceuticals Forecast EPS vs Actual EPS